Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA.
N Engl J Med. 2021 Feb 18;384(7):630-642. doi: 10.1056/NEJMoa2008283.
Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA.
Obstet Gynecol. 2022 Dec 1;140(6):920-930. doi: 10.1097/AOG.0000000000004988. Epub 2022 Nov 2.
Benign metastasizing leiomyoma of bone and lung in postmenopausal women: two rare case reports and review of the literature.
Cirak Y, Sever ON, Urun Y.
Eur J Gynaecol Oncol. 2017;38(1):118-121.
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
Syed YY.
Drugs. 2022 Oct;82(15):1549-1556. doi: 10.1007/s40265-022-01790-4. Epub 2022 Nov 4.
Non-Odontogenic Tumors of the Jaws.
Shaw SE, Chan CH.
2023 Jul 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Leiomyoma of iliac bone.
Balachandra B, Lee MW, Nguyen GK.
Can J Surg. 2007 Dec;50(6):E33-4.
Intraosseous leiomyoma of the calcaneum: An unusual bone tumor of foot and review of literature.
Salunke AA, Vala PC, Singh H, Parwani R, Gandhi S, Shah D.
J Clin Orthop Trauma. 2016 Oct-Dec;7(Suppl 1):61-64. doi: 10.1016/j.jcot.2016.08.001. Epub 2016 Oct 19.
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma.
Sandberg AA.
Cancer Genet Cytogenet. 2005 Apr 1;158(1):1-26. doi: 10.1016/j.cancergencyto.2004.08.025.
Leiomyoma of the Foot and Ankle: A Case Series.
Szolomayer LK, Talusan PG, Chan WF, Lindskog DM.
Foot Ankle Spec. 2017 Jun;10(3):270-273. doi: 10.1177/1938640016670243. Epub 2016 Sep 20.
PET/CT of delayed uterine leiomyoma metastasizing to lung and femur.
Huynh KN, Nguyen BD.
J Nucl Med Technol. 2022 Jul 26:jnmt.122.263901. doi: 10.2967/jnmt.122.263901. Online ahead of print.
